tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (CLVLF)
OTHER OTC:CLVLF
US Market
Advertisement

Clinuvel Pharmaceuticals (CLVLF) Ratios

Compare
41 Followers

Clinuvel Pharmaceuticals Ratios

CLVLF's free cash flow for Q4 2025 was AU$0.68. For the 2025 fiscal year, CLVLF's free cash flow was decreased by AU$ and operating cash flow was AU$0.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
9.66 8.81 7.44 10.24 11.81
Quick Ratio
9.34 8.39 7.06 10.10 11.45
Cash Ratio
8.24 7.29 0.94 2.00 4.27
Solvency Ratio
1.21 1.31 1.05 1.12 2.60
Operating Cash Flow Ratio
1.51 1.47 1.45 2.90 2.21
Short-Term Operating Cash Flow Coverage
0.00 0.00 -2.29 -5.48 0.00
Net Current Asset Value
AU$ 232.03MAU$ 193.95MAU$ 159.72MAU$ 121.33MAU$ 93.02M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.01 0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.13 1.14 1.18 1.15 1.10
Debt Service Coverage Ratio
0.00 8.27 -2.43 -4.32 15.81
Interest Coverage Ratio
0.00 10.78 12.81 14.55 16.50
Debt to Market Cap
0.00 0.00 -0.02 >-0.01 0.00
Interest Debt Per Share
0.01 0.10 0.08 0.07 0.06
Net Debt to EBITDA
-4.75 -3.53 -0.49 -0.75 -1.35
Profitability Margins
Gross Profit Margin
77.03%91.23%64.59%70.93%73.38%
EBIT Margin
48.30%62.52%62.27%55.68%56.97%
EBITDA Margin
49.54%58.82%59.20%53.37%55.39%
Operating Profit Margin
46.16%54.44%52.23%50.34%55.65%
Pretax Profit Margin
54.25%57.47%58.19%52.22%53.60%
Net Profit Margin
38.07%40.41%39.08%31.77%51.54%
Continuous Operations Profit Margin
38.07%40.41%39.08%31.77%51.54%
Net Income Per EBT
70.17%70.32%67.15%60.83%96.17%
EBT Per EBIT
117.55%105.57%111.41%103.74%96.32%
Return on Assets (ROA)
13.31%15.42%15.73%14.42%22.78%
Return on Equity (ROE)
15.79%17.55%18.59%16.63%25.04%
Return on Capital Employed (ROCE)
17.93%23.31%24.20%25.24%26.73%
Return on Invested Capital (ROIC)
12.56%16.36%17.93%16.21%25.64%
Return on Tangible Assets
13.32%15.43%15.76%14.45%22.85%
Earnings Yield
6.68%4.57%3.46%2.85%1.63%
Efficiency Ratios
Receivables Turnover
3.46 3.36 3.53 4.06 2.98
Payables Turnover
8.56 3.30 9.93 73.71 5.50
Inventory Turnover
2.47 0.73 2.91 10.43 4.01
Fixed Asset Turnover
13.33 11.42 27.47 24.34 18.43
Asset Turnover
0.35 0.38 0.40 0.45 0.44
Working Capital Turnover Ratio
0.42 0.49 0.54 0.59 0.60
Cash Conversion Cycle
210.35 499.48 192.08 120.03 147.07
Days of Sales Outstanding
105.49 108.61 103.53 89.98 122.40
Days of Inventory Outstanding
147.51 501.57 125.29 35.00 91.08
Days of Payables Outstanding
42.65 110.70 36.74 4.95 66.41
Operating Cycle
253.00 610.18 228.82 124.98 213.48
Cash Flow Ratios
Operating Cash Flow Per Share
0.82 0.73 0.75 0.81 0.39
Free Cash Flow Per Share
0.81 0.62 0.73 0.80 0.37
CapEx Per Share
<0.01 0.11 0.02 <0.01 0.02
Free Cash Flow to Operating Cash Flow
0.99 0.85 0.97 0.99 0.96
Dividend Paid and CapEx Coverage Ratio
14.66 4.61 12.29 23.88 9.22
Capital Expenditure Coverage Ratio
137.64 6.64 35.92 91.78 22.55
Operating Cash Flow Coverage Ratio
77.75 42.12 36.92 31.73 14.78
Operating Cash Flow to Sales Ratio
0.43 0.42 0.47 0.61 0.40
Free Cash Flow Yield
7.53%4.04%4.06%5.37%1.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.40 21.88 28.87 35.14 61.34
Price-to-Sales (P/S) Ratio
5.49 8.84 11.28 11.16 31.62
Price-to-Book (P/B) Ratio
2.16 3.84 5.37 5.84 15.36
Price-to-Free Cash Flow (P/FCF) Ratio
12.78 24.77 24.62 18.61 82.41
Price-to-Operating Cash Flow Ratio
12.68 21.04 23.93 18.40 78.75
Price-to-Earnings Growth (PEG) Ratio
-2.22 1.36 0.61 -2.20 1.00
Price-to-Fair Value
2.16 3.84 5.37 5.84 15.36
Enterprise Value Multiple
6.32 11.50 18.56 20.17 55.73
Enterprise Value
318.26M 596.62M 860.59M 707.59M 1.48B
EV to EBITDA
6.76 11.50 18.56 20.17 55.73
EV to Sales
3.35 6.77 10.99 10.77 30.87
EV to Free Cash Flow
7.80 18.95 23.98 17.94 80.46
EV to Operating Cash Flow
7.74 16.10 23.31 17.75 76.89
Tangible Book Value Per Share
4.80 3.97 3.32 2.53 1.99
Shareholders’ Equity Per Share
4.81 3.98 3.33 2.54 2.00
Tax and Other Ratios
Effective Tax Rate
0.30 0.30 0.33 0.39 0.04
Revenue Per Share
1.90 1.73 1.59 1.33 0.97
Net Income Per Share
0.72 0.70 0.62 0.42 0.50
Tax Burden
0.70 0.70 0.67 0.61 0.96
Interest Burden
1.12 0.92 0.93 0.94 0.94
Research & Development to Revenue
0.08 0.03 0.02 0.02 0.01
SG&A to Revenue
0.28 0.02 0.02 0.02 0.02
Stock-Based Compensation to Revenue
0.01 0.07 0.11 0.09 0.05
Income Quality
1.14 1.04 1.21 1.91 0.78
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis